Effective Pfizer and Oxford vaccines against the Corona variant found in India

 London: The Oxford or AstraZeneca corona vaccine and Pfizer's corona vaccine are effective against the B1.617.2 variant found in India. Evidence of this has been found in a recent study. According to the British government, these two vaccines are 80 percent effective against the B1.617.2 variant.The Oxford or Estrogen Gene Corona Vaccine is one of the corona vaccines being given in India. Most of the adults in the country are being vaccinated. The vaccine is being developed in India by the Serum Institute of India.

Two doses of these vaccines are 87 percent effective against the B.117 variant, according to data from Public Health England (PHE). This variant of the Corona was first found in the Kent area of ​​England. This variant was rapidly spreading in the human body. According to media reports, new data has emerged after the latest study was released to the government. According to the latest PHE figures released earlier this week, the number of cases in the B1.617.2 variant is much lower than last week.While last week there were 3,424 cases in the country, this week the number of cases is 2,111. Sanger Institute (Sanger Institute) Kovid-19 Genomics Director. Jeffrey Barrett said, "I clearly think it's improving. If anyone notices week after week, he will understand. ”

Until recently, British scientists were worried about the new variant B1.617.2 of the coronavirus (Covid-19) discovered in India. Anthony Herndon, deputy chairman of the Joint Committee on Vaccination and Immunization (JCVI) and a professor at Oxford University, said it was not yet clear how the new variant discovered in India could have an impact. No evidence has yet been found as to how quickly it affects the human body. However, after the survey, Britain is probably much relieved.